Yangbing Zhao
91 works · 14,587 citations · h-index 47
Top works
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- CRISPR-engineered T cells in patients with refractory cancer
- Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 Stability
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
- Primary Human Lymphocytes Transduced with NY-ESO-1 Antigen-Specific TCR Genes Recognize and Kill Diverse Human Tumor Cell Lines
- A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
- Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCR
- Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
- High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- Adoptive Immunotherapy for Cancer or Viruses
- Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
- A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication